Biological | Cellular Uptake |
Hong, S. Y.; Borchert, G. L.; Maciag, A. E.; Nandurdikar, R. S.; Saavedra, J. E.; Keefer, L.K.; Phang, J. M.; Chakrapani, H. The Nitric Oxide Prodrug V-PROLI/NO Inhibits Cellular Uptake of Proline. ACS Medicinal Chemistry Letters 2010, 1 (8), 386-389.
|
Pubmed Abstract
|
Biological | Mechanism of Action |
Qu, W.; Cheng, L.; Dill, A. L.; Saavedra, J. E.; Hong, S. Y.; Keefer, L. K.; Waalkes, M. P. Nitricoxide donor, V-PROLI/NO, provides protection against arsenical induced toxicityin rat liver cells: requirement for Cyp1a1. Chem. -Biol. Interact. 2011, 193 (1), 88-96.
|
Pubmed Abstract
|
Biological | Protects Against Arsenic Toxicity in Liver Cells |
Qu, W.; Liu, J.; Dill, A. L.; Saavedra, J. E.; Keefer, L. K.; Waalkes, M. P. V-PROLI/NO, a nitric oxide donor prodrug, protects liver cells from arsenic-induced toxicity. Can. Sci. 2009, 100 (3), 382-388.
|
Pubmed Abstract
|
Chemical | Preparation |
Chakrapani, H.; Showalter, B. M.; Kong, L.; Keefer, L. K.; Saavedra, J. E. V-PROLI/NO, a Prodrug of the Nitric Oxide Donor, PROLI/NO. Org. Lett. 2007, 9 (17), 3409-3412.
|
Pubmed Abstract
|
Patent | |
Saavedra, J. E.; Keefer, L. K. O2-substituted 1-[(2-carboxylato)pyrrolidin-1-yl]diazen-1-ium-1,2-diolates. U.S. Patent 7,081,524, July 25, 2006.
|
Patent 7081524 Full Text
|